Autologous chondrocyte bead-type cell therapy (Biosolution)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAutologous chondrocyte bead-type cell therapy (Biosolution)
Drug Alias NameCartiLife
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Cartilage cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiosolution Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiosolution Co Ltd
Inactive CompaniesN/A
Active IndicationsCartilage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia